Paul B. Manning, Director: Candel Therapeutics CADL Buy · Filed 24/12/18

Trade details

Type: Insider buy
Amount: $4,500,000
Shares · price: 750,000 sh · $6.00 a share
Held after: 1,303,752 sh
Stock: Candel Therapeutics CADL
Person: Paul B. ManningDirector
Trade date: 24/12/16
Filed: 24/12/18
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +135.4%

Candel Therapeutics trades, last 26 weeks

What else happened in Candel Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/16~25/01/15

Paul B. Manning's recent trades

Paul B. ManningDirector
SellLiquidia
Sell
Liquidia
LQDA
$5.7M
88,487 sh
$5.7M
Filed 06/08
Traded 06/04
Paul B. ManningDirector
SellLiquidia
Sell
Liquidia
LQDA
$4.4M
68,265 sh
$4.4M
Filed 06/08
Traded 06/04
Paul B. ManningDirector
SellLiquidia
Sell
Liquidia
LQDA
$1.2M
19,125 sh
$1.2M
Filed 06/08
Traded 06/04
Paul B. ManningDirector
SellLiquidia
Sell
Liquidia
LQDA
$812.3K
12,610 sh
$812.3K
Filed 06/08
Traded 06/04
Paul B. ManningDirector
SellLiquidia
Sell
Liquidia
LQDA
$726.8K
11,513 sh
$726.8K
Filed 06/08
Traded 06/04

Paul B. Manning, Director — bought $4.5M of Candel Therapeutics CADL · 750,000 sh @ $6.00 | Whalegun